Safety and Efficacy of Low Dose CD19 Targeted Chimeric Antigen Receptor T (CAR-T) Cell Immunotherapy in 47 Cases with Relapsed Refractory B-Cell Acute Lymphoblastic Leukemia (B-ALL)

被引：6
|
作者：
Deng, Biping [1 ]
Chang, Alex Hongsheng [2 ]
Yang, Junfang [3 ]
Pan, Jing [3 ]
Zhang, Xian [3 ]
Lin, Yuehui [3 ]
Wu, Yanan [1 ]
Deng, Zhenling [1 ]
Lu, Peihua [3 ]
Wu, Tong [4 ]
Liu, Zhaoli [1 ]
Zhang, Yu'e [1 ]
Tong, Chunrong [3 ]
机构：
[1] Hebei Yanda Lu Daopei Hosp, Immunotherapy Dept, Langfang, Peoples R China
[2] Tongji Univ, Sch Med, Shanghai, Peoples R China
[3] Hebei Yanda Lu Daopei Hosp, Hematopathol, Langfang, Peoples R China
[4] Hebei Yanda Lu Daopei Hosp, Bone Marrow Transplantat, Langfang, Peoples R China
来源：
BLOOD | 2016年 / 128卷 / 22期
关键词：
D O I：
10.1182/blood.V128.22.649.649
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
649
引用
收藏
页数：7
相关论文
共 50 条
  • [21] Treatment of CML-transformed B Cell Acute Lymphoblastic Leukemia (B-ALL) in Adults with Anti-CD19 Chimeric Antigen Receptor T Cell (CAR T) Therapy
    Liu, Fang
    Sha, Sha
    Ma, Gina
    Su, Yi
    Xiong, Yisong
    He, Guangcui
    Li, Yecheng
    Hanes, William M.
    Tse, William
    STEM CELL REVIEWS AND REPORTS, 2020, 16 (06) : 1356 - 1358
  • [22] CD19 chimeric antigen receptor (CD19 CAR)-redirected adoptive T-cell immunotherapy for the treatment of relapsed or refractory B-cell Non-Hodgkin's Lymphomas
    Onea, Alexandra S.
    Jazirehi, Ali R.
    AMERICAN JOURNAL OF CANCER RESEARCH, 2016, 6 (02): : 403 - 424
  • [23] Dendritic Cell Vaccines Extend CD19 CAR-T Cell Persistence and Improve the Outcomes in Refractory/Relapsed Adult B-ALL
    Tu, Sanfang
    Zhou, Lijuan
    Huang, Rui
    He, Yanjie
    Zhou, Xuan
    Yang, Jilong
    Hu, Yuxing
    Zhang, Honghao
    Chang, Lung-Ji
    Li, Yuhua
    BLOOD, 2023, 142
  • [24] Chimeric Antigen Receptor (CAR) T Cells Targeting the CD19 Antigen for the Treatment of Pediatric Relapsed B Cell ALL
    Curran, Kevin J.
    Riviere, Isabelle
    Kobos, Rachel
    Kernan, Nancy A.
    Boulad, Farid
    Prockop, Susan E.
    Scaradavou, Andromachi
    Renaud, Thomas M.
    Shukla, Neerav
    Steinherz, Peter G.
    Park, Jae H.
    Sauter, Craig S.
    O'Reilly, Richard J.
    Sadelain, Michel
    Brentjens, Renier J.
    BLOOD, 2014, 124 (21)
  • [25] Checkpoint Inhibitors Augment CD19-Directed Chimeric Antigen Receptor (CAR) T Cell Therapy in Relapsed B-Cell Acute Lymphoblastic Leukemia
    Li, Amanda M.
    Hucks, George E.
    Dinofia, Amanda M.
    Seif, Alix E.
    Teachey, David T.
    Baniewicz, Diane
    Callahan, Colleen
    Fasano, Christina
    McBride, Beth
    Gonzalez, Vanessa
    Nazimuddin, Farzana
    Porter, David L.
    Lacey, Simon F.
    June, Carl H.
    Grupp, Stephan A.
    Maude, Shannon L.
    BLOOD, 2018, 132
  • [26] Combination of CD19 and CD22 CAR-T cell therapy in relapsed B-cell acute lymphoblastic leukemia after allogeneic transplantation
    Liu, Shuangyou
    Deng, Biping
    Yin, Zhichao
    Lin, Yuehui
    An, Lihong
    Liu, Dan
    Pan, Jing
    Yu, Xinjian
    Chen, Bingzhen
    Wu, Tong
    Chang, Alex H.
    Tong, Chunrong
    AMERICAN JOURNAL OF HEMATOLOGY, 2021, 96 (06) : 671 - 679
  • [27] CD22 Gating for Flow Cytometric Analysis in Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia after CD19 CAR-T Therapy
    Yu, Xinjian
    Li, Pan
    Feng, Heyuan
    Kang, Jian
    Zheng, Xichang
    Zhang, Yunmei
    Yang, Wenhong
    Wu, Tong
    Liu, Shuangyou
    BLOOD, 2020, 136
  • [28] CD4+CD25+CD127low regulatory T cells associated with the effect of CD19 CAR-T therapy for relapsed/refractory B-cell acute lymphoblastic leukemia
    Pan, Ying
    Wang, Huiping
    An, Furun
    Wu, Fan
    Tao, Qianshan
    Li, Yingwei
    Ruan, Yanjie
    Zhai, Zhimin
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2021, 96
  • [29] Analysis of Factors Predicting Treatment Response of 254 Patients Who Received CD19-Targeted CAR-T Cell Therapy for Relapsed/Refractory (R/R) B-Cell Acute Lymphoblastic Leukemia (B-ALL)
    Zhang, Xian
    Yang, Junfang
    Shi, Yanze
    Song, Dan
    Li, Jingjing
    Lu, Xin-an
    Wu, Fei
    Li, Jianqiang
    Chen, Dandan
    Li, Xiangqun
    Xu, Zhongwei
    Liu, Shuqiang
    Li, Ziyu
    Ying, Kui
    Wang, Wenya
    Lu, Peihua
    BLOOD, 2019, 134
  • [30] CD19/CD22 Dual-Targeted Chimeric Antigen Receptor T-Cell Therapy for Relapsed/Refractory Aggressive B-Cell Lymphoma: a Safety and Efficacy Study
    Hu, Yongxian
    Zhang, Yanlei
    Zhao, Houli
    Wang, Yiyun
    Nagler, Arnon
    Chang, Alex Hong
    Huang, He
    BLOOD, 2020, 136
12345